Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics (NASDAQ: COYA), a clinical-stage biotechnology company, announced the sale of $26.5 million worth of stock in a...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics (NASDAQ: COYA), a clinical-stage biotechnology company, announced a development-and-license deal with Dr. Reddy’s Laboratories for its...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler represented Coya Therapeutics in the transaction. Coya Therapeutics, Inc. (Nasdaq: COYA), a clinical-stage biotechnology company developing proprietary therapies to enhance the function of regulatory...
You must be a Standard 1 Year member to access this content.
